ICR Clinical Trials & Statistics Unit (ICR-CTSU)
http://www.icr.ac.uk/our-research/our-research-centres/clinical-trials-and-statistics-unit
ICR-CTSU is a research-led, academic clinical trials unit (CTU) within the Division of Clinical Studies at the ICR. Our expertise spans the whole clinical trial life cycle. We receive core funding from Cancer Research UK, are a UK Clinical Research Collaborative (UKCRC) registered CTU and one of 15 CTUs recognised by the National Cancer Research Institute (NCRI) for professional specialism in the development and delivery of cancer trials. ICR-CTSU is committed to the responsible sharing of clinical trial data and trial samples with the wider research community in order to improve scientific and medical knowledge about cancer. To enable data and samples to be effectively shared with others, an access policy and defined procedure exist to ensure that relevant legal, ethical and commercial constraints are recognised and that data and samples are made available for new research purposes in a responsible manner. Please consult the data sharing page for further information.
- ctsu@icr.ac.uk
- SOP status
- Agreed standards in place, no assessment of accreditation
Biobanks in this network
- TOPARP: Ph. II Trial of Olaparib in Patients with advanced CRPC
- TNT: Triple Negative breast cancer Trial
- POETIC: Trial of perioperative endocrine therapy – individualising care
- NICAM: Nilotinib treatment for c-KIT mutated advanced AMM
- EPHOS-B Trial
- CASPS: A Phase II trial of Cediranib in ASPS patients
- RE-AKT